Translational Pediatrics,
Год журнала:
2024,
Номер
13(2), С. 318 - 328
Опубликована: Фев. 1, 2024
In
the
context
of
global
pandemic
coronavirus
disease
2019
(COVID-19),
more
than
700
million
infections
and
millions
deaths
have
occurred
in
countries
around
world.
Currently,
two
main
sequelae
this
are
considered
to
occur
children,
namely,
multi-system
inflammatory
syndrome
children
long
COVID.
Among
these
two,
incidence
COVID
is
higher
its
impact
on
population
extensive,
which
focus
us.
However,
due
lack
relevant
studies
limitations
most
studies,
COVID-19
infection
lag
behind
those
adults,
but
they
begun
attract
attention
some
clinicians
researchers.
We
aim
summarize
current
knowledge
helping
pediatricians
researchers
better
understand
providing
guidance
research
clinical
treatment
it.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Март 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
Journal of Personalized Medicine,
Год журнала:
2023,
Номер
13(2), С. 334 - 334
Опубликована: Фев. 15, 2023
More
than
two
years
after
the
onset
of
COVID-19
pandemic,
healthcare
providers
are
facing
an
emergency
within
emergency,
so-called
long
COVID
or
post-COVID-19
syndrome
(PCS).
Patients
diagnosed
with
PCS
develop
extended
range
persistent
symptoms
and/or
complications
from
COVID-19.
The
risk
factors
and
clinical
manifestations
many
various.
Advanced
age,
sex/gender,
pre-existing
conditions
certainly
influence
pathogenesis
course
this
syndrome.
However,
absence
precise
diagnostic
prognostic
biomarkers
may
further
complicate
management
patients.
This
review
aimed
to
summarize
recent
evidence
on
influencing
PCS,
possible
biomarkers,
therapeutic
approaches.
Older
patients
recovered
approximately
one
month
earlier
younger
patients,
higher
rates
symptoms.
Fatigue
during
acute
phase
appears
be
important
factor
for
symptom
persistence.
Female
sex,
older
active
smoking
associated
a
developing
PCS.
incidence
cognitive
decline
death
in
controls.
Complementary
alternative
medicine
improvement
symptoms,
particularly
fatigue.
heterogeneous
nature
post-COVID
complexity
who
often
polytreated
due
concomitant
conditions,
suggest
holistic
integrated
approach
provide
useful
guidance
treatment
overall
COVID.
Virus Research,
Год журнала:
2023,
Номер
334, С. 199157 - 199157
Опубликована: Июнь 26, 2023
COVID-19,
an
infectious
respiratory
illness,
is
caused
by
infection
with
the
SARS-CoV-2
virus.
Individuals
underlying
medical
conditions
are
at
increased
risk
of
developing
serious
illnesses
such
as
long
COVID.
Recent
studies
have
observed
Epstein-Barr
virus
(EBV)
reactivation
in
patients
severe
illness
or
COVID,
which
may
contribute
to
associated
symptoms.
We
determined
frequency
EBV
COVID-19
positive
compared
negative
patients.
106
blood
plasma
samples
were
collected
from
and
was
detection
DNA
antibodies
against
lytic
genes
individuals
previous
infection.
27.1%
(13/48)
reactivations,
based
on
qPCR
genomes,
COVID
group
while
only
12.5%
(6/48)
reactivations
belonged
group.
20/52
(42.30%)
PCR
had
detectable
nucleoprotein
(Np);
indicative
past
A
significantly
higher
Np
protein
level
found
In
conclusion,
experienced
comparison
Frontiers in Cardiovascular Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Сен. 1, 2023
Long
COVID
is
characterized
by
persistent
signs
and
symptoms
that
continue
or
develop
for
more
than
4
weeks
after
acute
COVID-19
infection.
Patients
with
experience
a
cardiovascular
autonomic
imbalance
known
as
dysautonomia.
However,
the
underlying
pathophysiological
mechanisms
behind
this
remain
unclear.
Current
hypotheses
include
neurotropism,
cytokine
storms,
inflammatory
persistence.
Certain
immunological
factors
indicate
autoimmune
dysfunction,
which
can
be
used
to
identify
patients
at
higher
risk
of
COVID.
Heart
rate
variability
imbalances
in
individuals
suffering
from
COVID,
measurement
non-invasive
low-cost
method
assessing
modulation.
Additionally,
biochemical
markers
are
diagnosing
monitoring
These
improve
understanding
driving
response
its
effects
on
sympathetic
parasympathetic
pathways
nervous
system.
Autonomic
may
result
lower
heart
variability,
impaired
vagal
activity,
substantial
sympathovagal
imbalance.
New
research
subject
must
encouraged
enhance
long-term
risks
cause
Vaccines,
Год журнала:
2023,
Номер
11(12), С. 1769 - 1769
Опубликована: Ноя. 27, 2023
Introduction:
The
impact
of
long-COVID-19
syndrome
is
rather
variable,
since
it
influenced
by
several
residual
confounders.
This
study
aimed
to
investigate
the
prevalence
long
COVID-19
in
healthcare
workers
(HCWs)
from
four
university
hospitals
north-eastern
Italy:
Trieste,
Padua,
Verona,
and
Modena-Reggio
Emilia.
Methods:
During
period
June
2022-August
2022,
HCWs
were
surveyed
for
past
infections,
medical
history,
any
acute
as
well
post-COVID-19
symptoms.
was
estimated
at
30-60
days
or
61+
first
negative
swab
following
second
episode.
Furthermore,
risk
investigated
multivariable
logistic
regression.
Results
expressed
adjusted
odds
ratio
(aOR)
with
a
95%
confidence
interval
(95%CI).
Results:
5432
returned
usable
questionnaire:
2401
infected
SARS-CoV-2
least
once,
230
twice,
8
three
times.
after
primary
infection
24.0%
versus
16.3%
days,
10.5%
against
5.5%
event.
most
frequent
symptoms
event
asthenia
(30.3%),
followed
myalgia
(13.7%),
cough
(12.4%),
dyspnea
(10.2%),
concentration
deficit
(8.1%),
headache
(7.3%),
anosmia
(6.5%),
decreasing
order
prevalence.
significantly
higher
hospitalized
(aOR
=
3.34;
95%CI:
1.62;
6.89),
those
during
early
pandemic
waves-namely
Wuhan
2.16;
1.14;
4.09)
Alpha
(aOR=
2.05;
1.25;
3.38)
transmission
periods-and
progressively
increasing
viral
shedding
time
(VST),
especially
15+
3.20;
2.07;
4.94).
Further
determinants
female
sex
1.91;
1.30;
2.80),
age
>40
years,
abnormal
BMI,
administrative
services
(reference
category).
In
contrast,
vaccinated
two
doses
before
their
0.57;
0.34;
0.94),
undergraduate
students,
postgraduate
trainees
less
likely
experience
days.
Apart
waves,
main
confirmed
Conclusions:
increased
severity
disease
VST,
initial
when
more
virulent
strains
circulating,
susceptibility
had
not
been
yet,
vaccines
still
available,
and/or
vaccination
coverage
building
up.
therefore
decreased
inversely
humoral
immunity
individual
level.
Nevertheless,
remarkably
lower
reinfections
regardless
status,
suggesting
that
hybrid
did
increase
protection
compared
mounted
either
natural
separately.
Since
currently
low
Omicron
patients
who
developed
waves
tend
return
state
full
health
time,
cost-effective
approach
screen
could
be
restricted
vulnerable
individuals
developing
severe
prolonged
VST.
PLoS ONE,
Год журнала:
2023,
Номер
18(10), С. e0292630 - e0292630
Опубликована: Окт. 13, 2023
The
majority
of
people
who
contract
COVID-19
experience
a
short
period
symptomatic
infection.
However,
symptoms
persist
for
months
or
years
following
initial
exposure
to
the
virus
in
some
cases.
This
has
been
described
as
long
COVID.
Little
is
known
about
lived
this
condition,
it
only
recently
emerged.
study
aimed
explore
experiences
mental
health,
quality
life,
and
coping
among
living
with
A
sample
47
adults
participated
web-based
focus
groups.
Separate
groups
were
held
24
individuals
pre-existing
health
conditions
23
without
conditions.
Data
analyzed
using
codebook
thematic
analysis
approach.
Five
themes
identified
integral
COVID
experience:
Emotional
Landscape
Long
COVID,
New
Limits
Daily
Functioning,
Grief
Loss
Former
Identity,
COVID-related
Stigmatization,
Learning
Cope
Persisting
Symptoms.
These
findings
illustrate
immense
impact
on
life.
Minimal
differences
found
between
those
conditions,
both
substantially
impacted
by
condition.
Attention
perspectives
necessary
inform
future
directions
research
clinical
practice.
American Journal of Medicine Open,
Год журнала:
2024,
Номер
11, С. 100068 - 100068
Опубликована: Фев. 14, 2024
The
virus
called
SARS-CoV-2
emerged
in
2019
and
quickly
spread
worldwide,
causing
COVID-19.
It
has
greatly
impacted
on
everyday
life,
healthcare
systems,
the
global
economy.
In
order
to
save
as
many
lives
possible,
precautions
such
social
distancing,
quarantine,
testing
policies
were
implemented,
effective
vaccines
developed.
A
growing
amount
of
data
collected
worldwide
allowed
characterization
this
new
disease,
which
turned
out
be
more
complex
than
other
common
respiratory
tract
infections.
An
increasing
number
convalescents
presented
with
a
variety
non-specific
symptoms
emerging
after
acute
infection.
This
possible
health
problem
was
identified
labelled
long
COVID.
Since
then,
great
effort
been
made
by
clinicians
scientific
community
understand
underlying
mechanisms
develop
preventive
measures
treatment.
role
autoimmunity
induced
infection
development
COVID
is
discussed
review.
We
aim
deliver
description
several
conditions
an
autoimmune
background
observed
COVID-19
convalescents,
including
Guillain-Barré
syndrome,
antiphospholipid
syndrome
related
thrombosis,
Kawasaki
disease
highlighting
relationship
between
autoimmunity.
However,
further
studies
are
required
determine
its
true
clinical
significance.